Hyperjaponol H, a New Bioactive Filicinic Acid-Based Meroterpenoid from Hypericum Japonicum Thunb. Ex Murray

Hyperjaponol H, a New Bioactive Filicinic Acid-Based Meroterpenoid from Hypericum Japonicum Thunb. Ex Murray

Hyperjaponol H, A New Bioactive Filicinic Acid-based Meroterpenoid from Hypericum japonicum Thunb. ex Murray Rongrong Wu 1,†, Zijun Le 2,†, Zhenzhen Wang 3, Shuying Tian 1, Yongbo Xue 3, Yong Chen 1, Linzhen Hu 1, * and Yonghui Zhang 3 1 National & Local Joint Engineering Research Center of High-throughput Drug Screening Technology, Hubei Key Laboratory of Biotechnology of Chinese Traditional Medicine, School of Life Science, Hubei University, Wuhan 430062, Hubei Province, P. R. China; E-mails: [email protected] (R. R. W.); [email protected] (S. Y. T.); [email protected] (Y. C.) 2 Wuhan Rayson School, Wuhan 430040, Hubei Province, P. R. China; E-mail: [email protected] (Z. J. L.) 3 Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology; Wuhan 430030, Hubei, China; E-mails : [email protected] (Z. Z. W.); [email protected] (Y. B. X.); [email protected] (Y. H. Z.) † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-mail: [email protected] (L. Z. H.); Tel.: +86-27-88668023 (L. Z. H.) Content Figure S1. HRESIMS spectrum of hyperjaponol H (1) ..................................................................... 1 1 Figure S2. H NMR spectrum of hyperjaponol H (1, in CDCl3) ....................................................... 2 13 Figure S3. C NMR and DEPT135 spectra of hyperjaponol H (1, in CDCl3) .................................. 3 Figure S4. HSQC spectrum of hyperjaponol H (1, in CDCl3) ........................................................... 4 Figure S5. HMBC spectrum of hyperjaponol H (1, in CDCl3) .......................................................... 5 1 1 Figure S6. H– H COSY spectrum of hyperjaponol H (1, in CDCl3) ................................................ 6 Figure S7. NOESY spectrum of hyperjaponol H (1, in CDCl3) ........................................................ 7 Figure S8. UV spectrum of hyperjaponol H (1, in methanol) ........................................................... 8 Figure S9. IR spectrum of hyperjaponol H (1, KBr disc) ................................................................ 9 x10 4 +ESI Scan (0.106 min) Frag=70.0V 20180308-WRR.P.1.d 459.3119 2.4 2.2 2 1.8 1.6 1.4 1.2 1 0.8 460.3157 0.6 0.4 0.2 0 458.5 459 459.5 460 460.5 461 461.5 462 462.5 463 463.5 464 Counts vs. Mass-to-Charge (m/z) Figure S1. HRESIMS spectrum of hyperjaponol H (1) 1 1 Figure S2. H NMR spectrum of hyperjaponol H (1, in CDCl3) 2 13 Figure S3. C NMR and DEPT135 spectra of hyperjaponol H (1, in CDCl3) 3 Figure S4. HSQC spectrum of hyperjaponol H (1, in CDCl3) 4 Figure S5. HMBC spectrum of hyperjaponol H (1, in CDCl3) 5 1 1 Figure S6. H– H COSY spectrum of hyperjaponol H (1, in CDCl3) 6 Figure S7. NOESY spectrum of hyperjaponol H (1, in CDCl3) 7 Figure S8. UV spectrum of hyperjaponol H (1, in methanol) 8 E:\20171130\20171130HULINZ\1.0 Transmittance [%] 4000 91.5 92.0 92.5 93.0 93.5 94.0 94.5 95.0 3921.83 3875.63 3826.53 3757.82 3720.07 3673.41 3500 Figure S9. Figure 3455.00 3111.42 3000 IR spectrum of hyperjaponol H ( 2966.81 2932.80 2874.83 2500 2528.70 Wavenumber cm-1 Wavenumber 2381.44 9 2307.27 2224.30 2000 1919.37 1720.64 1 1654.55 , KBr disc) , KBrdisc) 1612.99 1500 1523.39 1464.58 1378.07 1313.52 1259.33 1189.42 1140.69 1000 1063.58 989.16 938.55 14:19:02 2017-11-30 881.82 821.45 752.01 676.82 619.55 500 579.85 501.85 457.07 .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    11 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us